Cargando…

BMI-1 Autoantibody as a New Potential Biomarker for Cervical Carcinoma

BMI-1 is overexpressed in a variety of cancers, which can elicit an immune response leading to the induction of autoantibodies. However, BMI-1 autoantibody as a biomarker has seldom been studied with the exception of nasopharyngeal carcinoma. Whether BMI-1 autoantibodies can be used as a biomarker f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Yong-Qing, Liu, Bei, Zheng, Hong-Yun, He, Yu-Juan, Gu, Jian, Li, Feng, Li, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221654/ https://www.ncbi.nlm.nih.gov/pubmed/22132147 http://dx.doi.org/10.1371/journal.pone.0027804

Ejemplares similares

Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2014)

Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
por: Liu, Wan-li, et al.
Publicado: (2010)

Autoantibodies as potential biomarkers for breast cancer
por: Zhong, Li, et al.
Publicado: (2008)

Serum anti-GAPDH autoantibody levels reflect the severity of cervical lesions: A potential serum biomarker for cervical cancer screening
por: Xu, Mei Ling, et al.
Publicado: (2019)

Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2017)

Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B
por: Qi, Saiping, et al.
Publicado: (2022)

Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection
por: Chen, Zhibin, et al.
Publicado: (2023)

A study on UHPLC-MS/MS analyses of DNA and RNA oxidative damage metabolites in patients with cervical carcinoma: 8-oxoG in urine as a potential biomarker of cervical carcinoma
por: Lin, Rong-Rong, et al.
Publicado: (2022)

Autoantibodies as Potential Biomarkers in Breast Cancer
por: Qiu, Jingyi, et al.
Publicado: (2018)

Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer
por: Jin, Yingji, et al.
Publicado: (2017)

Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma
por: Wang, Ting, et al.
Publicado: (2017)

Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma
por: Chen, Huili, et al.
Publicado: (2022)

Autoantibody Biomarkers in Rheumatic Diseases
por: Kang, Eun Ha, et al.
Publicado: (2020)

Expression of Bmi-1, P16, and CD44v6 in Uterine Cervical Carcinoma and Its Clinical Significance
por: Weng, Mei-ying, et al.
Publicado: (2012)

Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)
por: Dai, Liping, et al.
Publicado: (2013)

Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma
por: SHAO, QING, et al.
Publicado: (2012)

Autoantibodies in Alzheimer’s disease: potential biomarkers, pathogenic roles, and therapeutic implications
por: Wu, Jianming, et al.
Publicado: (2016)

Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma
por: Ying, Xia, et al.
Publicado: (2017)

Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma
por: Lin, Lie-Hao, et al.
Publicado: (2017)

Autoantibodies against p53, MMP-7, and Hsp70 as Potential Biomarkers for Detection of Nonmelanoma Skin Cancers
por: Yang, Shi-Han, et al.
Publicado: (2021)

Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer
por: Li, Jitian, et al.
Publicado: (2016)

Tissue-based metabolomics reveals potential biomarkers for cervical carcinoma and HPV infection
por: Abudula, Abulizi, et al.
Publicado: (2020)

Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma
por: Li, Yang, et al.
Publicado: (2020)

Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma
por: Ma, Yangcheng, et al.
Publicado: (2022)

Serum Sp17 Autoantibody Serves as a Potential Specific Biomarker in Patients with SAPHO Syndrome
por: You, Hongqin, et al.
Publicado: (2021)

Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice
por: Qi, Shibo, et al.
Publicado: (2014)

Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics
por: Zhou, Huihui, et al.
Publicado: (2019)

Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma
por: Wang, Hejing, et al.
Publicado: (2020)

Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018)

Autoantibody signature in hepatocellular carcinoma using seromics
por: Zhang, Shu, et al.
Publicado: (2020)

Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma
por: Wang, Chen, et al.
Publicado: (2022)

Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma
por: Li, Lan, et al.
Publicado: (2017)

Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2019)

Apoptosis-induced translocation of centromere protein F in its corresponding autoantibody production in hepatocellular carcinoma
por: Li, Xiaojin, et al.
Publicado: (2021)

Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker
por: Hu, Qiongyi, et al.
Publicado: (2018)

MGMT autoantibodies as a potential prediction of recurrence and treatment response biomarker for glioma patients
por: Wu, Haibin, et al.
Publicado: (2019)

Autoantibodies against tumor-associated antigens in sputum as biomarkers for lung cancer
por: Li, Ning, et al.
Publicado: (2020)

Biomarkers of Cervical Dysplasia and Carcinoma
por: Hwang, Sonya J., et al.
Publicado: (2012)

Cervical Carcinoma: Oncobiology and Biomarkers
por: Volkova, Larisa V., et al.
Publicado: (2021)

Overexpression of microRNA-132 enhances the radiosensitivity of cervical cancer cells by down-regulating Bmi-1
por: Liu, Gui-Feng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vt58a9qpcikdoj2i3qjspu9v89